Flubendazole in cystic echinococcosis therapy: Pharmaco-parasitological evaluation in mice

Parasitology International

Volumn 58, Issue 4, 2009, Pages 354-358

  Ceballos, Laura ^a,c   Elissondo, María ^b,c   Bruni, Sergio Sánchez ^a,c   Denegri, Guillermo ^b,c   Alvarez, Luis ^a,c   Lanusse, Carlos ^a,c  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE MAR DEL PLATA   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cyclodextrins; Cystic echinococcosis; Flubendazole

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; FLUBENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; ECHINOCOCCOSIS; HISTOPATHOLOGY; MALE; MAXIMUM PLASMA CONCENTRATION; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SECONDARY INFECTION; SUSPENSION; TREATMENT OUTCOME;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; MALE; MEBENDAZOLE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; PHARMACEUTICAL SOLUTIONS; TREATMENT OUTCOME;

ECHINOCOCCUS GRANULOSUS; MUS;

EID: 70349838505     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2009.07.006     Document Type: Article

References (30)

1. Jenkins D.J., Romig T., and Thompson R.C.A. Emergence/re-emergence of Echinococcus spp.-a global update. Int J Parasitol 35 (2005) 1205-1219
2. McManus D.P., Zhang W., Li J., and Bartley P.B. Echinococcosis. Lancet 362 (2003) 1295-1304
3. Budke C., Desplazes M.P., and Torgerson P.R. Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis 12 (2006) 296-303
4. Eckert J, Schantz PM, Gasser RB, Torgerson PR, Bessonov AS, Movsessian SO, et al. Geographic distribution and prevalence. In: Eckert J, Gemmell MA, Meslin FX, Pawlowski ZS, editors. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. WHO/WOAH, Paris; 2001, pp. 100-142.
5. Pawlowski Z.S., Eckert J., Vuitton D.A., Ammann R.W., Kemp P., Craig P.S., et al. Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J., Gemmell M.A., Meslin F.X., and Pawlowski Z.S. (Eds). WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern (2001), Office International des Epizooties, Paris 20-66
6. Menezes da Silva A. Hydatid cyst of the liver-criteria for the selection of appropriate treatment. Acta Trop 85 (2003) 237-242
7. El-On J. Benzimidazole treatment of cystic echinococcosis. Acta Trop 85 (2003) 243-252
8. World Health Organization Informal Working Group of Echinococcosis. Puncture, aspiration, injection, re-aspiration. An option for the treatment of cystic echinococcosis (2001), World Health Organization, Geneva, Switzerland 1-40
9. Davis A., Pawlowski Z.S., and Dixon H. Multicenter trials of benzimidazole-carbamates in human echinococcosis. Bull World Health Organ 64 (1986) 333-388
10. Lanusse C.E., and Prichard R.K. Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab Rev 25 (1993) 235-279
11. Ceballos L., Elissondo C., Moreno L., Dopchiz M., Sánchez Bruni S., Denegri G., et al. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations. Parasitol Res 103 (2008) 355-362
12. García J., Bolás F., and Torrado J.J. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. Int J Pharm 250 (2003) 351-358
13. Stettler M., Rossignol J.F., Fink R., Walker M., Gottstein B., Merli M., et al. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int J Parasitol 34 (2004) 615-624
14. Elissondo M., Ceballos L., Dopchiz M., Andresiuk M.V., Alvarez L., Sánchez Bruni S., et al. In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes. Parasitol Res 100 (2007) 1003-1009
15. Recco P., Hornus E., Frejevus J., Micheau P., Bessieres M.H., Roques C., et al. Hydatidose pleurale disseminee et hydatidoses hepatiques. Traitment post-operatoire par flubendazole a proposde 3 cas. Bull Soc Fr Parasitol 3 (1984) 115-118
16. Elissondo M., Dopchiz M., Ceballos L., Alvarez L., Sanchez Bruni S., Lanusse C.E., et al. In vitro effects of flubendazole on Echinococcus granulosus protoscoleces. Parasitol Res 98 (2006) 317-323
17. McKellar Q., Galbraith E., and Baxter P. Oral absorption and bioavailability of fenbendazole in the dog and the effects of concurrent ingestion of food. J Vet Pharmacol Ther 13 (1993) 223-227
18. Martins P.S., Ochoa R., Pimenta A.M.C., Ferreira L.A.M., Melo A.L., Da Silva J.B.B., et al. Mode of action of β-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate. Int J Pharm 325 (2006) 39-47
19. Castillo J.A., Palomo-Canales J., García J.J., Lastres J.L., and Torrado J.J. Preparation and characterization of albendazole beta-cyclodextrin complexes. Drug Dev Ind Pharm 25 (1999) 1241-1248
20. Evrard B., Chiap P., DeTullio F., Ghalmid F., Piela G., Van Heesa T., et al. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin. J Control Release 85 (2002) 45-50
21. Casado N., Rodríguez-Caabeiro F., and Hernández S. In vitro survival of Echinococcus granulosus protoescoleces in several media, at 4 °C and 37 °C. Z Parasitenkd 72 (1986) 273-278
22. Elissondo M., Dopchiz M., Brasesco M., and Denegri G. Echinococcus granulosus: first report of microcysts formation from protoscoleces of cattle origin using the in vitro vesicular culture technique. Parasite 11 (2004) 415-418
23. Gibaldi M., and Perrier D. Pharmacokinetics. Revised and expanded. 2nd ed (1982), Marcel Dekker, New York, NY, USA 45-109
24. Motulsky H. Introduction to advanced statistical tests. In: Intuitive biostatistics. Oxford University editor. USA 1995; p. 245-268.
25. Moreno L., Alvarez L., Mottier L., Virkel G., Sanchéz Bruni S., and Lanusse C.E. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability. J Vet Pharmacol Ther 27 (2004) 299-308
26. Alvarez L., Mottier M., and Lanusse C.E. Drug transfer into target helminth parasites. Trends Parasitol 23 (2007) 97-104
27. Casado N., Urrea París M.A., Moreno M.J., and Rodriguez Caabeiro F. Combined praziquantel and albendazole chemoprophylaxis in experimental hidatidosis. Parasitol Res 87 (2001) 787-789
28. García Llamazares J., Alvarez de Felipe A.I., Redondo Cardena P.A., and Prieto Fernandez J.G. Fertility and viability study of ovine hydatid cysts. Rev Esp Salud Pública 71 (1997) 445-449
29. Spicher M., Naguleswaran A., and Ortega-Mora L.M. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes. Exp Parasitol 119 (2008) 467-474
30. Vamparijs O. Chemotherapy of experimental Echinococcus multilocularis in jirds. Parasitol Res 76 (1990) 238-240